Member Info for Bennster

Still too many people here trying to wish this upwards, hoping group positivity will somehow make it real - looking for any crumbs. Reality can be hard but you need to face it - cjinvests's post yesterday really stood out for me.
Making out TB placing to himself is a good thing? We're further diluted this morning.
Re-heating the old COVID chestnut?
In truth there could still be a bit of a spike after year end - based on Phasefocus, not Paraytec. but that gives those bitten here an opportunity to time an exit at minimum pain. After that......

you got your wish - TB has indeed released an RNS and helped himself.....

You couldn't make it up!
We got a NO vote to stop this in the coming year so they used last year's permissions to hand out some shares anyway....and guess who snaffled some...

Could be last knockings on the tax year - get that investment into your ISA before CoP tonight?
Either way, it's better than a dig in the eye with a sharp stick.

a powerful post cjinvest.
I am anticipating (and it's just an educated guess folks) that the future SP will be affected by what BRH does with Phasefocus.
A) They sell it for a big profit and pay a divi - if this happens we'll get a SP spike (and a chance to exit stage left) before the inevitable tumble and placing later in 2022.
B) They keep Phasefocus and bank a higher balance sheet valuation, or sell and reinvest the proceeds - this won't give BRH the big SP spike, but equally it should ensure long term value doesn't dip below 20p for long and should allow it to grow longer term.
CX300 outcomes I agree are long, long term (but may eventually reap rewards).

calculation3 - I too believe that BRH's best near term value is Phasefocus - you may not be far off with your valuation estimate. I hold LT because after year end results I think we'll see a better SP based on this reality.
The work and effort that's gone into the CX300 isn't wasted if it delivers sepsis and bladder cancer uses, but that's 18 months away.
I do wish some could see that the whole COVID application has gone. It's still seen by some as the whole of BRH's future.

Lifted directly from the RNS as posted by Starknight:

"Braveheart's board believes that after the completion of the prospective clinical study, scheduled to be concluded by the end of June 2022 and provide clinical proof of concept of the CX300 technology platform, it would be in the best interests of shareholders that Paraytec focus on the development of the sepsis and bladder cancer applications for its technology. "

In other words don't hold your breath for a COVID application.....

Still we overlook Phasefocus.
That was the primary source of increased value at the half yearly results.
If TB is buying it's more likely to be Phasefocus news.

I'm still happy to see 5% every day :-)
This share has doubled in 2022... long may it prosper.

Not sure what's more offensive Starknight. Your drunken homophobia in the small hours or the fact 3 people saw fit to recommend such a post.
Why should anybody have assumptions like this made as an insult against them and feel they have to post denials? You made up a homophobic twist on my user name without any reason to other than you're a sad individual.
Enough is enough - reported.
If you had any valid points to make you may deserve some respect but you have earned none here. I'm sure most sensible readers of this message board will know that nobody has laughed and gloated at anybody, and using words like "traitor" is just ludicrous.
Go away and review your whole life and approach.
I also appeal to those anonymous souls who recommended your post to stand up and explain what they found so appealing.

Space Cadet - your inability to read let alone get any facts straight is legendary.
I've never tried to get anybody to believe there would be a major sell off. Indeed, the only opinion I've ventured is that there could be a spike in the next couple of months on TB buying and year end results....
I made it clear nobody knows whether TB might sell any after the GM, I think he may hold.
Put the bottle down.

I did today ;-)

And sadly more churn today - any link to the recent placing? I hope not.
Might be year end B&B to be fair.

well I feel for you - I'm sat on a small loss here, but still hopeful if there's a takeover or at least some director change this can be a good long term investment.
May your next venture be more fruitful.

Definitely should have saved that one for tomorrow morning Richie

TB's plans may have been disrupted by this vote Skippsy.
In 2021 he got that big 26% share of BRH along with FAB - it came as a non-pre-emptive distribution on a closed placing at a bargain price.
This year, amazingly, we've got a NO on that motion - this precludes TB from getting a massive placement to his benefit. I don't think he would have expected that "rebellion" and it may affect his plans.
He could have bought for a year end rise in SP, or to bolster his vote share given the large volume of NO votes coming in by proxy. Who knows.

Tough call whether he will sell any or all - I suspect he'll wait a bit, see what year end results bring in terms of a spike.
In the mean time there might be some TB fan posters here with certain opinions who will be selling in a sulk... ;-)
We live in hope.

WOW!!!

We actually got a NO to non-pre-emptive distribution!!! Hurrah!!

I think we all understand what you are "Regulator UK"
I'm sure none of us like it very much.

Nowhere did acaciatan libel anybody. He/she quoted some facts and figures and then a belief. If you can read you'll see the words "I believe".....
Why are you jumping about accusing anybody of libel? You are coming across more and more as a BRH board member determined to defend TB's actions.